UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial Journal article
Zeng, Qing Bin, Zou, De Cheng, Huang, Xing Bing, Shang, De Wei, Huang, Xiong, Yang, Xin Hu, Ning, Yu Ping, Balbuena, Lloyd, Xiang, Yu Tao, Zheng, Wei. Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial[J]. Journal of Affective Disorders, 2025, 368, 320-328.
Authors:  Zeng, Qing Bin;  Zou, De Cheng;  Huang, Xing Bing;  Shang, De Wei;  Huang, Xiong; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:4.9/5.4 | Submit date:2025/01/22
Electroconvulsive Therapy  Esketamine  Propofol  Rct  Treatment-resistant Depression  
Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies Journal article
Zheng,Wei, Cai,Dong Bin, Xiang,Ying Qiang, Jiang,Wen Long, Sim,Kang, Ungvari,Gabor S., Huang,Xiong, Huang,Xing Xiao, Ning,Yu Ping, Xiang,Yu Tao. Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies[J]. Journal of Affective Disorders, 2020, 265, 63-70.
Authors:  Zheng,Wei;  Cai,Dong Bin;  Xiang,Ying Qiang;  Jiang,Wen Long;  Sim,Kang; et al.
Favorite | TC[WOS]:67 TC[Scopus]:73  IF:4.9/5.4 | Submit date:2021/03/02
Depression  Intranasal Esketamine  Meta-analysis  Remission  Response